X-152868898-T-C

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP4

The NM_015922.3(NSDHL):​c.904T>C​(p.Tyr302His) variant causes a missense change. The variant allele was found at a frequency of 0.00000826 in 1,210,534 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y302N) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0000089 ( 0 hom., 1 hem., cov: 24)
Exomes 𝑓: 0.0000082 ( 0 hom. 1 hem. )

Consequence

NSDHL
NM_015922.3 missense

Scores

6
11

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 6.54

Publications

1 publications found
Variant links:
Genes affected
NSDHL (HGNC:13398): (NAD(P) dependent steroid dehydrogenase-like) The protein encoded by this gene is localized in the endoplasmic reticulum and is involved in cholesterol biosynthesis. Mutations in this gene are associated with CHILD syndrome, which is a X-linked dominant disorder of lipid metabolism with disturbed cholesterol biosynthesis, and typically lethal in males. Alternatively spliced transcript variants with differing 5' UTR have been found for this gene. [provided by RefSeq, Jul 2008]
NSDHL Gene-Disease associations (from GenCC):
  • CHILD syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet, G2P
  • CK syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), ClinGen, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.40502447).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NSDHLNM_015922.3 linkc.904T>C p.Tyr302His missense_variant Exon 8 of 8 ENST00000370274.8 NP_057006.1
NSDHLNM_001129765.2 linkc.904T>C p.Tyr302His missense_variant Exon 9 of 9 NP_001123237.1
NSDHLNM_001441099.1 linkc.904T>C p.Tyr302His missense_variant Exon 10 of 10 NP_001428028.1
NSDHLXM_017029564.2 linkc.952T>C p.Tyr318His missense_variant Exon 8 of 8 XP_016885053.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NSDHLENST00000370274.8 linkc.904T>C p.Tyr302His missense_variant Exon 8 of 8 1 NM_015922.3 ENSP00000359297.3
NSDHLENST00000440023.5 linkc.904T>C p.Tyr302His missense_variant Exon 9 of 9 5 ENSP00000391854.1

Frequencies

GnomAD3 genomes
AF:
0.00000889
AC:
1
AN:
112503
Hom.:
0
Cov.:
24
show subpopulations
Gnomad AFR
AF:
0.0000323
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000218
AC:
4
AN:
183391
AF XY:
0.0000147
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000365
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000244
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000820
AC:
9
AN:
1098031
Hom.:
0
Cov.:
31
AF XY:
0.00000275
AC XY:
1
AN XY:
363385
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26400
American (AMR)
AF:
0.0000284
AC:
1
AN:
35205
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19385
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30205
South Asian (SAS)
AF:
0.0000185
AC:
1
AN:
54144
European-Finnish (FIN)
AF:
0.0000247
AC:
1
AN:
40526
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4137
European-Non Finnish (NFE)
AF:
0.00000713
AC:
6
AN:
841940
Other (OTH)
AF:
0.00
AC:
0
AN:
46089
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000889
AC:
1
AN:
112503
Hom.:
0
Cov.:
24
AF XY:
0.0000289
AC XY:
1
AN XY:
34639
show subpopulations
African (AFR)
AF:
0.0000323
AC:
1
AN:
30921
American (AMR)
AF:
0.00
AC:
0
AN:
10683
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2653
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3576
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2714
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6236
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
240
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53280
Other (OTH)
AF:
0.00
AC:
0
AN:
1514

Age Distribution

Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378
ExAC
AF:
0.0000330
AC:
4
EpiCase
AF:
0.00
EpiControl
AF:
0.000119

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:1
Apr 25, 2016
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Uncertain:1
Jun 13, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces tyrosine, which is neutral and polar, with histidine, which is basic and polar, at codon 302 of the NSDHL protein (p.Tyr302His). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 436070). This variant has not been reported in the literature in individuals affected with NSDHL-related conditions. This variant is present in population databases (rs782181497, gnomAD 0.006%), including at least one homozygous and/or hemizygous individual. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.32
BayesDel_addAF
Benign
-0.070
T
BayesDel_noAF
Benign
-0.19
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Benign
0.37
T;T
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Benign
0.83
T;.
M_CAP
Benign
0.066
D
MetaRNN
Benign
0.41
T;T
MetaSVM
Uncertain
0.14
D
MutationAssessor
Uncertain
2.2
M;M
PhyloP100
6.5
PrimateAI
Uncertain
0.58
T
PROVEAN
Benign
-1.2
N;N
REVEL
Uncertain
0.47
Sift
Benign
0.53
T;T
Sift4G
Benign
0.51
T;T
Polyphen
0.99
D;D
Vest4
0.26
MutPred
0.52
Loss of loop (P = 0.1242);Loss of loop (P = 0.1242);
MVP
0.86
MPC
0.28
ClinPred
0.47
T
GERP RS
4.1
Varity_R
0.20
gMVP
0.90
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs782181497; hg19: chrX-152037442; API